Arthritis: Its prevalence, Risk factors, And association with cardiovascular diseases in the United States, 1999 to 2008

Annals of Epidemiology

Volumn 23, Issue 2, 2013, Pages 80-86

  Ong, Kwok Leung ^a,b   Wu, Ben J ^a   Cheung, Bernard M Y ^c   Barter, Philip J ^a,b   Rye, Kerry Anne ^a,b,d  

^a HEART RESEARCH INSTITUTE   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Arthritis; Cardiovascular risk; NHANES; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SELF REPORT; UNITED STATES;

EID: 84872167048     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.11.008     Document Type: Article

References (31)

1. Helmick C.G., Felson D.T., Lawrence R.C., Gabriel S., Hirsch R., Kwoh C.K., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008, 58:15-25.
2. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008, 58:26-35.
3. Dillon C.F., Rasch E.K., Gu Q., Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol 2006, 33:2271-2279.
4. Symmons D.P., Gabriel S.E. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011, 7:399-408.
5. U.S. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Hyattsville (MD): United States Department of Health and Human Services, Centers for Disease Control and Prevention. 1999-2008 [accessed 1.30.12]. http://www.cdc.gov/nchs/nhanes.htm.
6. U.S. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Examination Protocol. Hyattsville (MD): United States Department of Health and Human Services, Centers for Disease Control and Prevention. 1999-2008 [accessed 1.30.12]. http://www.cdc.gov/nchs/nhanes.htm.
7. U.S. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Laboratory Protocol. Hyattsville, Maryland: United States Department of Health and Human Services, Centers for Disease Control and Prevention. 1999-2008 [accessed 1.30.12]. http://www.cdc.gov/nchs/nhanes.htm.
8. U.S. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). NHANES Data Release and Access Policy. [accessed 11.1.12]. http://www.cdc.gov/nchs/data/nhanes/nhanes_release_policy.pdf.
9. U.S. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, Maryland: United States Department of Health and Human Services, Centers for Disease Control and Prevention. 1999-2008 [accessed 1.30.12]. http://www.cdc.gov/nchs/nhanes.htm.
10. Ong K.L., Wu B.J., Cheung B.M., Barter P.J., Rye K.A. Association of lower total bilirubin level with statin usage: The United States National Health and Nutrition Examination Survey 1999-2008. Atherosclerosis 2011, 219:728-733.
11. Li M., Ong K.L., Tse H.F., Cheung B.M. Utilization of lipid lowering medications among adults in the United States 1999-2006. Atherosclerosis 2010, 208:456-460.
12. Hennekens C.H., Buring J.E. Epidemiology in medicine 1987, Little, Brown, and Co, Boston.
13. van Halm V.P., Nielen M.M., Nurmohamed M.T., van Schaardenburg D., Reesink H.W., Voskuyl A.E., et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007, 66:184-188.
14. Myasoedova E., Crowson C.S., Kremers H.M., Fitz-Gibbon P.D., Therneau T.M., Gabriel S.E. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2010, 69:1310-1314.
15. Choy E., Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis 2009, 68:460-469.
16. Toms T.E., Panoulas V.F., Smith J.P., Douglas K.M., Metsios G.S., Stavropoulos-Kalinoglou A., et al. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Ann Rheum Dis 2011, 70:1025-1032.
17. Corsetti J.P., Ryan D., Moss A.J., McCarthy J., Goldenberg I., Zareba W., et al. Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels. Thromb Haemost 2011, 106:1170-1178.
18. Ragbir S., Farmer J.A. Dysfunctional high-density lipoprotein and atherosclerosis. Curr Atheroscler Rep 2010, 12:343-348.
19. Charles-Schoeman C., Watanabe J., Lee Y.Y., Furst D.E., Amjadi S., Elashoff D., et al. Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum 2009, 60:2870-2879.
20. Park Y.B., Choi H.K., Kim M.Y., Lee W.K., Song J., Kim D.K., et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002, 113:188-193.
21. Lee Y.H., Choi S.J., Ji J.D., Seo H.S., Song G.G. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 2000, 19:324-325.
22. Myasoedova E., Crowson C.S., Kremers H.M., Roger V.L., Fitz-Gibbon P.D., Therneau T.M., et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011, 70:482-487.
23. Lip G.Y., Barnett A.H., Bradbury A., Cappuccio F.P., Gill P.S., Hughes E., et al. Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens 2007, 21:183-211.
24. Shah T., Newcombe P., Smeeth L., Addo J., Casas J.P., Whittaker J., et al. Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction. Circ Cardiovasc Genet 2010, 3:436-444.
25. Nelson A.E., Renner J.B., Schwartz T.A., Kraus V.B., Helmick C.G., Jordan J.M. Differences in multijoint radiographic osteoarthritis phenotypes among African Americans and Caucasians: the Johnston County Osteoarthritis project. Arthritis Rheum 2011, 63:3843-3852.
26. Davis J.M., Roger V.L., Crowson C.S., Kremers H.M., Therneau T.M., Gabriel S.E. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008, 58:2603-2611.
27. Hippisley-Cox J., Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005, 330:1366-1369.
28. Antman E.M., Bennett J.S., Daugherty A., Furberg C., Roberts H., Taubert K.A. American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007, 115:1634-1642.
29. McGettigan P., Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 2011, 8:e1001098.
30. Altman R.D., Barthel H.R. Topical therapies for osteoarthritis. Drugs 2011, 71:1259-1279.
31. Geyer M., Müller-Ladner U. Rationale of using different biological therapies in rheumatoid arthritis. Arthritis Res Ther 2010, 12:214.